MENLO THERAPEUTICS INC - COM (MNLO)

CUSIP: 586858102

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class
Equity / COM
Total 13F shares
14,257,728
Share change
-1,155,339
Total reported value
$115,953,908
Price per share
$8.12
Number of holders
46
Value change
-$55,051,648
Number of buys
25
Number of sells
23

Quarterly Holders Quick Answers

What is CUSIP 586858102?
CUSIP 586858102 identifies MNLO - MENLO THERAPEUTICS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of MENLO THERAPEUTICS INC - COM (MNLO) as of Q2 2018

As of 30 Jun 2018, MENLO THERAPEUTICS INC - COM (MNLO) was held by 46 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 14,257,728 shares. The largest 10 holders included Vivo Capital, LLC, JANUS HENDERSON GROUP PLC, venBio Partners L.P., Novo Holdings A/S, PERCEPTIVE ADVISORS LLC, FMR LLC, BAKER BROS. ADVISORS LP, BlackRock Inc., Rock Springs Capital Management LP, and DAFNA Capital Management LLC. This page lists 46 institutional shareholders reporting positions in this security for the Q2 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.